There has been a great deal of scientific research on the therapeutic aspects of PCOS/hirsutism/acne, which has intensified more recently. A PubMed search on “Treatment of polycystic ovary syndrome” returned 3580 items published in the 51 years comprised between 1957 and March 04, 2008; of these, 607 (17%) were in the 2 years, between Jan 01, 2006 and March 04, 2008. A PubMed search on “Treatment of hirsutism” returned 2211 items published in the 57 years comprised between 1951 and March 04, 2008; of these, 192 (9%) were in the 2 years between Jan 01, 2006 and March 04, 2008. At the recent 13th World Congress on Gynecological Endocrinology (Florence, February 28-March 02, 2008), 15 oral presentations and 3 posters focused on treatment of PCOS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kiddy DS, Hamilton-Fairley D, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992; 36:105–11
Koulouri O, Conway GS. A systematic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol (Oxf). 2008 Feb 14 [Epub ahead of print]
Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008; 23: 462–77
Sonino N, Fava GA, Mani E et al. Quality of life of irsute women. Postgrad Med J 1993; 69:186–189
Shapiro J, Lui H. Vaniqa – eflornithine 13.9% cream. Skin Therapy Lett 2001; 6:1–3
http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID=14852 (accessed March 04, 2008)
Califano L, Cannavò S, Siragusa M, et al. Experience in the therapy of acne with topical administration of spironolactone as an antiandrogen. Clin Ter 1990; 15;135:193–99
Berardesca E, Gabba P, Ucci G, et al. Topical spironolactone inhibits dihydrotestosterone receptors in human sebaceous glands: an autoradiographic study in subjects with acne vulgaris. Int J Tissue React 1988; 10:115–19.
Richards RN, Uy M, Meharg G. Temporary hair removal in patients with hirsutism: a clinical study. Cutis 1990; 45: 199–202.
(http://www.fda.gov/cdrh/consumer/laserfacts.html updated February 28, 2008) (accessed, March 04, 2008)
Haedersdal M, Wulf HC. Evidence-based review of hair removal using lasers and light sources. J Eur Acad Dermatol Venereol 2006; 20: 9–20
Sadighha A, Mohaghegh Zahed G. Meta-analysis of hair removal laser trials. Lasers Med Sci 2007 Nov 20 [Epub ahead of print]
Loo WJ, Lanigan SW. Laser treatment improves quality of life of hirsute females. Clin Exp Dermatol 2002; 27 :439–41
Clayton WJ, Lipton M, Elford J, et al. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 2005; 152: 986–92
Conroy FJ, Venus M, Monk B. A qualitative study to assess the effectiveness of laser epilation using a qualify-of-life scoring system. Clin Exp Dermatol 2006; 31:753–56
Hamzavi I, Tan E, Shapiro J, et al. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol 2007; 57:54–9.
Meyer C, McGrath BP, Teede HJ. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007; 30: 471–78
http://www.notmypill.org/ (accessed March 04, 2008)
Elter K, Imir G, Durmusoglu F. Clinical endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovary syndrome: a randomized controlled study. Human Reprod 2002; 17: 1729–37
Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, et al. Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92:2453–61
De Leo V, Fulghesu AM, La Marca A et al. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism. Gynecol Endocrinol. 2000; 14:411–16
Carmina E, Lobo RA. A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women. Clin Endocrinol (Oxf) 2002; 57:231–34.
Swiglo BA, Cosma M, Flynn DN, et al. Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab. 2008 Apr;93(4):1153–60. Epub 2008 Feb 5.
Ibáñez L, Jaramillo A, Ferrer A, et al. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women. Hum Reprod 2005; 20:1833–36.
Ibáñez L, Ong K, Ferrer A, et al. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism. J Clin Endocrinol Metab 2003; 88:2600–06.
Ibáñez L, López-Bermejo A, del Rio L, et al. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess. J Clin Endocrinol Metab 2007; 92:1710–14.
Venturoli S, Marescalchi O, Colombo FM, et al. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism J Clin Endocrinol Metab 1999; 84:1304–10
Moghetti P, Tosi F, Tosti A, et al. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2000; 85:89–94
Müderris II, Bayram F, Güven M. prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism. Fertil Steril 2000; 73:984–87
Farquhar C, Lee O Toomath R, et al. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne Cochrane database Syst Rev 2003; 4:CD000194
Van der Spuy ZM, le Roux PA. Cyproterone acetate for hirsutism. Cochrane database Syst Rev 2003; 4:CD001125
Gambineri A, Patton L, Vaccina A, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study J Clin Endocrinol 2006; 91:3970–80
Calaf J, Lopez E, Millet A, et al. Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial. J Clin Endocrinol Metab 2007; 92:3446–52
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Benvenga, S. (2009). Therapy of Hirsutism. In: Farid, N.R., Diamanti-Kandarakis, E. (eds) Diagnosis and Management of Polycystic Ovary Syndrome. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09718-3_19
Download citation
DOI: https://doi.org/10.1007/978-0-387-09718-3_19
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-09717-6
Online ISBN: 978-0-387-09718-3
eBook Packages: MedicineMedicine (R0)